Welcome to SynapCell
SynapCell is a biotechnology company providing the CNS drug manufacturing industry with translational drug discovery solutions to reveal the therapeutic potential of their molecules targeting CNS disorders.
Meet SynapCell in May at AED Trials XIII -Miami- and ADD Symposium -Park City-
AED Trials 13–15 May, ADD Symposium 17–20 May
Two major congresses for epilepsy drug discovery are taking place this May in the USA, and of course we will be there!
First will be held the AED Trials XIII Conference in Miami on May 13 to 15, followed from May 17 to 20 by the ADD symposium in Park city, Utah.
The need of novel therapies for patient is very strong in the epilepsy community. These two events will try to bring inputs, each focusing on different issues.
AED Trials XIII will re-evaluate strategies related to antiepileptic drug (AED) development, from preclinical discoveries through clinical evaluations, to ensure continued advancement, as there is always the opportunity to learn from the past to improve the future. www.aedtrials.com
ADD Symposium’s goal is to explore how innovative breakthroughs in basic science can be leveraged by public, federal, and private partnerships to rapidly develop new treatments for the patient with epilepsy. ADD symposium wishes to facilitate new knowledge, new collaborations, and new insight into state of the art of therapy development. www.addsymposium.com
SynapCell will be attending both meeting, presenting talks about our new solutions for epilepsy drug discovery. We are excited to meet you there!